MSCI上調中國平安(02318.HK)ESG評級至A級
中國平安(02318.HK)(601318.SH)宣布,近日獲MSCI調升ESG評級,從BBB上調至A級,位列綜合保險和經紀行業亞太區第一。MSCI評級報告顯示,此次調升主要是基於中國平安在「普惠金融」方面領先行業,以及「負責任投資、氣候變化脆弱性、公司治理和公司行為」等方面的顯著提升,同時認同集團不斷深化的負責任投資實踐和綠色金融五年目標。
中國平安表示,未來將繼續堅持商業價值與社會價值的有機結合,不斷為客戶創造「省心、省時、又省錢」的金融、醫療生活服務體驗,進一步完善ESG相關政策與實踐,推動ESG治理水準提升,深入貫徹落實可持續發展戰略,為客戶、員工、股東、社會持續創造穩健增長的價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.